These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38096231)

  • 1. "It would really support the wider harm reduction agenda across the board": A qualitative study of the potential impacts of drug checking service delivery in Scotland.
    Falzon D; Parkes T; Carver H; Masterton W; Wallace B; Craik V; Measham F; Sumnall H; Gittins R; Hunter C; Watson K; Mooney JD; Aston EV
    PLoS One; 2023; 18(12):e0292812. PubMed ID: 38096231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges for drug checking services in Scotland: a qualitative exploration of police perceptions.
    Falzon D; Aston EV; Carver H; Masterton W; Wallace B; Sumnall H; Measham F; Fletcher E; Gittins R; Priyadarshi S; Parkes T
    Harm Reduct J; 2022 Sep; 19(1):105. PubMed ID: 36138440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Realist Review of How Community-Based Drug Checking Services Could Be Designed and Implemented to Promote Engagement of People Who Use Drugs.
    Masterton W; Falzon D; Burton G; Carver H; Wallace B; Aston EV; Sumnall H; Measham F; Gittins R; Craik V; Schofield J; Little S; Parkes T
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contested space in the pharmacy: public attitudes to pharmacy harm reduction services in the West of Scotland.
    Gidman W; Coomber R
    Res Social Adm Pharm; 2014; 10(3):576-87. PubMed ID: 24021859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'It's not going to be a one size fits all': a qualitative exploration of the potential utility of three drug checking service models in Scotland.
    Carver H; Falzon D; Masterton W; Wallace B; Aston EV; Measham F; Hunter C; Sumnall H; Gittins R; Raeburn F; Craik V; Priyadarshi S; Rothney L; Weir K; Parkes T
    Harm Reduct J; 2023 Jul; 20(1):94. PubMed ID: 37501057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Why would we not want to keep everybody safe?' The views of family members of people who use drugs on the implementation of drug consumption rooms in Scotland.
    Parkes T; Price T; Foster R; Trayner KMA; Sumnall HR; Livingston W; Perkins A; Cairns B; Dumbrell J; Nicholls J
    Harm Reduct J; 2022 Aug; 19(1):99. PubMed ID: 36038919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A peer-delivered intervention to reduce harm and improve the well-being of homeless people with problem substance use: the SHARPS feasibility mixed-methods study.
    Parkes T; Matheson C; Carver H; Foster R; Budd J; Liddell D; Wallace J; Pauly B; Fotopoulou M; Burley A; Anderson I; MacLennan G
    Health Technol Assess; 2022 Feb; 26(14):1-128. PubMed ID: 35212621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential impacts of community drug checking within the overdose crisis: qualitative study exploring the perspective of prospective service users.
    Wallace B; van Roode T; Pagan F; Hore D; Pauly B
    BMC Public Health; 2021 Jun; 21(1):1156. PubMed ID: 34134698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users.
    Wallace B; van Roode T; Pagan F; Phillips P; Wagner H; Calder S; Aasen J; Pauly B; Hore D
    Harm Reduct J; 2020 May; 17(1):29. PubMed ID: 32398090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "You know, we can change the services to suit the circumstances of what is happening in the world": a rapid case study of the COVID-19 response across city centre homelessness and health services in Edinburgh, Scotland.
    Parkes T; Carver H; Masterton W; Falzon D; Dumbrell J; Grant S; Wilson I
    Harm Reduct J; 2021 Jun; 18(1):64. PubMed ID: 34118942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance Use Stigma and Community Drug Checking: A Qualitative Study Examining Barriers and Possible Responses.
    Davis S; Wallace B; Van Roode T; Hore D
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36498052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating networked drug checking services in Toronto, Ontario: study protocol and rationale.
    Maghsoudi N; McDonald K; Stefan C; Beriault DR; Mason K; Barnaby L; Altenberg J; MacDonald RD; Caldwell J; Nisenbaum R; Leece P; Watson TM; Tupper KW; Kufner L; Scheim AI; Werb D;
    Harm Reduct J; 2020 Jan; 17(1):9. PubMed ID: 32204713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Third party drug checking: accessing harm reduction services on the behalf of others.
    Larnder A; Burek P; Wallace B; Hore DK
    Harm Reduct J; 2021 Sep; 18(1):99. PubMed ID: 34535157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study.
    Schofield J; Dumbrell J; Matheson C; Parkes T; Bancroft A
    BMC Public Health; 2022 Mar; 22(1):500. PubMed ID: 35287630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.
    Wiessing L; Ferri M; Běláčková V; Carrieri P; Friedman SR; Folch C; Dolan K; Galvin B; Vickerman P; Lazarus JV; Mravčík V; Kretzschmar M; Sypsa V; Sarasa-Renedo A; Uusküla A; Paraskevis D; Mendão L; Rossi D; van Gelder N; Mitcheson L; Paoli L; Gomez CD; Milhet M; Dascalu N; Knight J; Hay G; Kalamara E; Simon R; ; Comiskey C; Rossi C; Griffiths P
    Harm Reduct J; 2017 Apr; 14(1):19. PubMed ID: 28431584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative assessment of key considerations for drug checking service implementation.
    Grace Rose C; Pickard AS; Kulbokas V; Hoferka S; Friedman K; Epstein J; Lee TA
    Harm Reduct J; 2023 Oct; 20(1):151. PubMed ID: 37848875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights from Drug Checking Programs: Practicing Bootstrap Public Health Whilst Tailoring to Local Drug User Needs.
    Ondocsin J; Ciccarone D; Moran L; Outram S; Werb D; Thomas L; Arnold EA
    Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297603
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.